Huicong Chemical Network News: Vencorex recently announced the official completion of its industrial product line series expansion project. The project includes expanding monomer (HDI and IPDI) production capacity at the PontdeClaix plant in France, and building a new Tolonate™ in Rayong, Thailand. HDI derivative production equipment, as well as a new Easaqua™ water-based polyurethane cross-linking agent derivative product line equipment in Freeport, Texas, USA.
According to Xavier Fournier, CEO of Vencorex, the completion of this series of expansion projects will make Vencorex a truly global enterprise with strong individual integration capabilities. The value chain will be further enhanced in the coming months when the company completes another modernization project for electrolytic chlorine production in France. As this foundation is established, Vencorex will invest further in derivatives line expansion.
At the end of 2014, Vencorex announced the expansion plan of HDI and IPDI at the PontdeClaix factory in France, with the new monomer production capacity reaching 70,000 tons. In December of that year, the company revealed that the project’s IPDI product expansion would add 20,000 tons of new production capacity. Previously, Vencorex Operating an IPDI monomer unit with an annual output of 5,000 tons in France.
At the same time, Vencorex also announced that it will build a new Tolonate™ HDI curing agent derivative product device in Thailand, with an annual production capacity of 12,000 tons.
In early 2016, Vencorex announced that it was expanding its Easaqu series water-based polyurethane cross-linking agent production capacity in North America.
Vencorex was established in May 2012 as a joint venture between Sweden’s Pestrop and Thailand’s PTT Global Chemical Business. In September 2014, PTTGC increased its shareholding to 34% by purchasing 34% of Pestrop’s shares. 85%, Perstorp’s shareholding was reduced to 15%. 
Editor in charge: Ye Dan
